Literature DB >> 2484297

Breakthrough pain: definition and management.

R K Portenoy1, N A Hagen.   

Abstract

Breakthrough pains are highly prevalent but poorly characterized phenomena that may be experienced by the cancer patient. The term encompasses a diverse group of transient pains that vary in their relationship to the fixed analgesic dose, temporal characteristics, precipitating events, predictability, pathophysiology, and etiology. Successful management is usually possible using a combination of primary oncologic interventions, optimization of the fixed analgesic regimen, and one or more of a variety of analgesic modalities, the mainstay of which is pharmacotherapy with a so-called "rescue-dose."

Entities:  

Mesh:

Year:  1989        PMID: 2484297

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  10 in total

1.  [Safety and efficacy of oral trans-mucosal fentanyl citrate in the long-term treatment of breakthrough pain in oncology patients: the ECODIR study].

Authors:  Vicente Valentín Maganto; Carlos Camps Herrero; Joan Carulla Torrent; Javier Cassinello Espinosa; Javier Dorta Delgado; Carlos Jara Sánchez; José Andrés Moreno Nogueira
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

Review 2.  Breakthrough cancer pain.

Authors:  Andrew N Davies
Journal:  Curr Pain Headache Rep       Date:  2014-06

3.  Comment on 'What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion'.

Authors:  Raffaele Giusti; Lucilla Verna; Daniela Iacono; Agnese Vannini; Corrado Ficorella; Giampiero Porzio
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 4.  The role of a pharmacist in ambulatory cancer pain management.

Authors:  Anna Ratka
Journal:  Curr Pain Headache Rep       Date:  2002-06

5.  Definition, prevalence and characteristics of sudden exhaustion: a possible syndrome of fatigue in cancer?

Authors:  Horng-Shiuann Wu; Jean E Davis
Journal:  Support Care Cancer       Date:  2012-08-15       Impact factor: 3.603

6.  Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats.

Authors:  Joshua Havelin; Ian Imbert; Devki Sukhtankar; Bethany Remeniuk; Ian Pelletier; Jonathan Gentry; Alec Okun; Timothy Tiutan; Frank Porreca; Tamara E King
Journal:  J Neurosci       Date:  2017-04-24       Impact factor: 6.167

7.  A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting.

Authors:  Sun Kyung Baek; Do Yeun Kim; Seok Yun Kang; Sun Jin Sym; Young Sung Kim; June Young Lee
Journal:  Cancer Res Treat       Date:  2015-09-15       Impact factor: 4.679

8.  Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.

Authors:  Jaume Canal-Sotelo; Javier Trujillano-Cabello; Philip Larkin; Núria Arraràs-Torrelles; Ramona González-Rubió; Mariona Rocaspana-Garcia; Eva Barallat-Gimeno
Journal:  BMC Palliat Care       Date:  2018-05-28       Impact factor: 3.234

9.  Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.

Authors:  Masoud Hashemi; Alireza Zali; Ebrahim Golmakani; Mohammad Hossein Delshad; Mahdi Shadnoush; Mohammad-Esmaeil Akbari
Journal:  Daru       Date:  2021-01-21       Impact factor: 3.117

10.  Breakthrough pain in patients with controlled or uncontrolled basal pain: an observational study.

Authors:  Antonio Gatti; Marta Gentili; Marco Baciarello; Marzia Lazzari; Rossella Marzi; Elisa Palombo; Alessandro Fabrizio Sabato; Giudo Fanelli
Journal:  Pain Res Manag       Date:  2014-06-19       Impact factor: 3.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.